ClarityCare Raises $16.5M to Automate the Payer Side of Prior Authorization

Most prior authorization automation money has gone to the provider side of the fax line: tools that assemble and submit requests faster. ClarityCare is selling to the other side. Its Series A, led by Headline, funds an AI agent that works inside health plans' utilization management queues, and the company says it can approve or escalate but never deny. For revenue cycle teams, the question is whether faster payer-side processing actually shows up as fewer delayed services, fewer authorization-related denials and less rework.

ClarityCare announced October 26 an oversubscribed $16.5 million Series A led by Headline, with new investors Arthur Ventures and FJ Labs and continued participation from Maverick, firstminute, Top Harvest Capital and Transpose Platform. The company says the round brings total funding to nearly $20 million; MedCity News puts the total at $19.8 million.

The San Francisco-based company says it will use the capital to grow its team, build new products and expand its footprint in the government sector.

12 days → 2 days

ClarityCare told MedCity News that for one of its seven current customers, its Electra agent cut prior authorization waits from 12 days to two, and that across its customer base it touches workflows affecting care for about 6 million people. These figures are company-reported and have not been independently verified by RevCycleAI.

What Electra Actually Does

ClarityCare describes itself as an "AI services company." Its product, Electra, checks each prior authorization request against clinical guidelines and member benefits and keeps an audit trail of how it reached each recommendation. According to the company, Electra can approve and escalate, but it never issues a denial. Cases it cannot approve go to a clinician.

With this release, the company says Electra now closes operational loops end to end: it works directly in fax inboxes, creates cases in utilization management systems, and prints letters and sends outbound faxes to close out authorizations.

CEO Hermine Tranie framed the product to MedCity News around three stages of a prior authorization: assembling the case, the clinical review, and closing the case after a decision. "Existing tools address one slice," she said. "Electra connects all three, automating the administrative work wherever possible, strengthening the clinician's review with summaries, recommendations and drafted communications, and completing the paperwork once the decision is made by the clinician."

MedCity reports that ClarityCare's customers include health plans, third-party administrators, medical management companies and government health services organizations that support Medicaid and Medicare programs.

The RCAI Signal

The no-denial design is the product's regulatory and reputational shield, and it is also the right lens for providers. An agent that can only say yes or "send to a human" speeds up approvals without automating adverse decisions. Providers should expect faster turnaround on clean, well-documented requests, and a remaining queue of escalated cases that still depends on clinician capacity at the plan.

Why the Timing Matters: CMS-0057-F

The round lands as impacted payers work through the CMS Interoperability and Prior Authorization final rule (CMS-0057-F). Under the rule, Medicare Advantage organizations, Medicaid and CHIP programs and managed care plans must send prior authorization decisions within 72 hours for expedited requests and seven calendar days for standard requests, and give a specific reason for denials. Those operational provisions generally began January 1, 2026. The rule's Prior Authorization API and other API requirements generally take effect January 1, 2027.

"Medicaid and Medicare Advantage plans face the most pressure from the new CMS rules," Tranie told MedCity, adding that the company is also growing with commercial plans across medical management and cost containment.

That split is useful for provider revenue cycle leaders. The decision-time clock is already running. The API mandate that is meant to move requests off fax and portals arrives in about two months. Until those APIs are widely live and used, a large share of payer-side intake will still arrive as faxes and documents, which is exactly the work ClarityCare is automating.

What It Means for Provider Revenue Cycle

Prior authorization sits upstream of some of the most avoidable revenue leakage in the cycle. When an authorization is slow, missing or mismatched to the service delivered, the result can be a rescheduled procedure, a write-off or a denial that has to be worked. Payer-side automation can help in several ways:

Faster approvals on complete requests: If plans approve well-documented cases sooner, scheduling and patient access teams spend less time chasing status.
Cleaner closure: Automated letters and outbound faxes may reduce "approved but never communicated" gaps that leave a provider unsure whether it can proceed.
More consistent documentation asks: Checking every request against the same criteria and benefits could make documentation requirements more predictable.

It also raises practical questions. Faster payer processing does not fix incomplete submissions, and escalated cases still wait on payer clinicians. Providers will rarely know which plans or delegated utilization management vendors use a tool like Electra, so the effect will show up, if at all, in payer-level turnaround and authorization denial trends rather than vendor dashboards.

Where ClarityCare Fits

Prior authorization AI now spans both sides of the transaction. Provider-side tools focus on detecting authorization requirements, gathering clinical documentation and submitting requests. Payer-side tools, ClarityCare included, focus on intake, case building and reviewer support inside utilization management. The CMS API mandate is meant to connect those sides electronically, which could eventually shrink the fax-and-document work both groups are automating today.

ClarityCare's bet on the government sector, Medicaid and Medicare Advantage plans and the organizations that administer them, puts it where CMS-0057-F applies most directly. Seven customers and a single headline turnaround result are early evidence, not proof of scale.

Questions Revenue Cycle Leaders Should Ask Their Payers

Turnaround reporting: Are the plan's CMS-0057-F prior authorization metrics published, and are expedited and standard decision times improving?
Escalation mix: What share of requests are approved without a clinician touching them, and how long do escalated cases take?
Denial reasons: Are denials arriving with the specific reasons the rule requires, in a form your team can act on?
Channel readiness: When will the plan accept requests through its Prior Authorization API, and will fax intake still be processed at the same speed?
Delegated vendors: If utilization management is delegated, who is the vendor, and what automation is in use?

RCAI Take

ClarityCare's $16.5 million round is modest by healthcare AI standards, but it points at a less crowded part of prior authorization: the payer's own back office.

The design choice to never deny makes the product easier to adopt and defend. For providers, the payoff depends on whether plans use the speed to approve more clean requests faster, rather than simply processing the same queue with fewer staff.

With CMS-0057-F decision clocks already in force and API deadlines on January 1, 2027, payer-side automation will be judged on one number providers can see: how fast an authorization comes back.

Sources: ClarityCare company announcement, October 26, 2026; Jenna Congdon, MedCity News, October 27, 2026; CMS fact sheet, CMS-0057-F. Financing details, customer counts, turnaround results and executive statements are attributed to the company and MedCity News; RevCycleAI's implications and questions are editorial analysis.